PMC:2940021 / 39255-39641 JSONTXT

{"project":"0_colil","denotations":[{"id":"20422195-19533640-60995","span":{"begin":378,"end":380},"obj":"19533640"},{"id":"20422195-15804248-60996","span":{"begin":382,"end":384},"obj":"15804248"}],"text":"In addition to the available cross-sectional data, it would be interesting to gain more longitudinal data in order to understand the disease evolution and the prognostic role of subclinical changes detected by MRI or ultrasound. In particular, the possible role of imaging for treatment monitoring is of great interest, and first approaches in metabolic diseases are promising [69, 70]."}

{"project":"2_test","denotations":[{"id":"20422195-19533640-29368079","span":{"begin":378,"end":380},"obj":"19533640"},{"id":"20422195-15804248-29368080","span":{"begin":382,"end":384},"obj":"15804248"}],"text":"In addition to the available cross-sectional data, it would be interesting to gain more longitudinal data in order to understand the disease evolution and the prognostic role of subclinical changes detected by MRI or ultrasound. In particular, the possible role of imaging for treatment monitoring is of great interest, and first approaches in metabolic diseases are promising [69, 70]."}

{"project":"TEST0","denotations":[{"id":"20422195-149-155-60995","span":{"begin":378,"end":380},"obj":"[\"19533640\"]"},{"id":"20422195-153-159-60996","span":{"begin":382,"end":384},"obj":"[\"15804248\"]"}],"text":"In addition to the available cross-sectional data, it would be interesting to gain more longitudinal data in order to understand the disease evolution and the prognostic role of subclinical changes detected by MRI or ultrasound. In particular, the possible role of imaging for treatment monitoring is of great interest, and first approaches in metabolic diseases are promising [69, 70]."}

{"project":"MyTest","denotations":[{"id":"20422195-19533640-29368079","span":{"begin":378,"end":380},"obj":"19533640"},{"id":"20422195-15804248-29368080","span":{"begin":382,"end":384},"obj":"15804248"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"In addition to the available cross-sectional data, it would be interesting to gain more longitudinal data in order to understand the disease evolution and the prognostic role of subclinical changes detected by MRI or ultrasound. In particular, the possible role of imaging for treatment monitoring is of great interest, and first approaches in metabolic diseases are promising [69, 70]."}